Literature DB >> 27108151

Diabetes Care in Iran: Where We Stand and Where We Are Headed.

Sina Noshad1, Mohsen Afarideh1, Behnam Heidari1, Jeffrey I Mechanick2, Alireza Esteghamati3.   

Abstract

BACKGROUND: The prevalence of diabetes has steadily increased in Iran from the time of the first published nationally representative survey in 1999 and despite efforts and strategies to reduce disease burden.
OBJECTIVES: The aim of the present review was to describe the current status of diabetes care in Iran.
METHODS: A selective review of the relevant literature, focusing on properly conducted studies, describing past and present diabetes care strategies, policies, and outcomes in Iran was performed.
FINDINGS: The quality of diabetes care has gradually improved as suggested by a reduction in the proportion of undiagnosed patients and an increase in affordability of diabetes medications. The National Program for Prevention and Control of Diabetes has proven successful at identifying high-risk individuals, particularly in rural and remote-access areas. Unfortunately, the rising tide of diabetes is outpacing these efforts by a considerable margin.
CONCLUSIONS: Substantial opportunities and challenges in the areas of prevention, diagnosis, and management of diabetes exist in Iran that need to be addressed to further improve the quality of care and clinical outcomes.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Iran; diabetes; diabetes epidemiology; health care policies; population surveillance; quality of care; type 2 diabetes

Mesh:

Substances:

Year:  2015        PMID: 27108151     DOI: 10.1016/j.aogh.2015.10.003

Source DB:  PubMed          Journal:  Ann Glob Health        ISSN: 2214-9996            Impact factor:   2.462


  21 in total

1.  Ottawa charter framework as a guide for type 2 diabetes prevention and control in Iran.

Authors:  Maryam Peimani; Ensieh Nasli-Esfahani; Elham Shakibazadeh
Journal:  J Diabetes Metab Disord       Date:  2019-03-19

Review 2.  Diabetes in the Middle East: Government Health Care Policies and Strategies that Address the Growing Diabetes Prevalence in the Middle East.

Authors:  Noor Al Busaidi; Prakash Shanmugam; Deepa Manoharan
Journal:  Curr Diab Rep       Date:  2019-02-04       Impact factor: 4.810

3.  High prevalence of diabetes in elderly of Iran: an urgent public health issue.

Authors:  Farid Fotouhi; Farhad Rezvan; Hassan Hashemi; Ali Javaherforoushzadeh; Mirgholamreza Mahbod; Abbasali Yekta; Zahra Jamshididana; Mehdi Khabazkhoob
Journal:  J Diabetes Metab Disord       Date:  2022-05-19

4.  Conceptual map of diabetes education: necessity of establishing iran diabetes academy.

Authors:  Mahnaz Sanjari; Maryam Aalaa; Mohammad Reza Amini; Neda Mehrdad; Hosein Adibi; Ensieh Nasli Esfahani; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2019-10-08

5.  Adherence to medications, self-care activity, and HbA1c status among patients with type 2 diabetes living in an urban area of Iran.

Authors:  Amir Jafarian-Amirkhizi; Amir Sarayani; Kheirollah Gholami; Maryam Taghizadeh-Ghehi; Kazem Heidari; Aarefeh Jafarzadeh-Kohneloo; Donald E Morisky
Journal:  J Diabetes Metab Disord       Date:  2018-10-25

6.  Estimating the attributable risk of vascular disorders in different ranges of fasting plasma glucose and assessing the effectiveness of anti-diabetes agents on risk reduction; questioning the current diagnostic criteria.

Authors:  Esmaeil Mohammadi; Fatemeh Sadeghi Morasa; Shahin Roshani; Bagher Larijani; Farshad Farzadfar; Negar Rezaei; Sina Azadnajafabad; Sahar Saeedi Moghaddam; Mehrdad Azmin; Maryam Karimian; Nima Fattahi; Kosar Jamshidi; Narges Ebrahimi; Mahtab Rouhifard Khalilabad; Shohreh Naderimagham
Journal:  J Diabetes Metab Disord       Date:  2020-11-16

7.  Glycemic control and associated factors among Iranian population with type 2 diabetes mellitus: a cross-sectional study.

Authors:  Sepideh Babaniamansour; Ehsan Aliniagerdroudbari; Mahtab Niroomand
Journal:  J Diabetes Metab Disord       Date:  2020-07-08

8.  Diagnostic validity of the pre-diabetes scale among at-risk rural Iranian adults for screening for pre-diabetes.

Authors:  Leila Jahangiry; Tahereh Shamizadeh; Parvin Sarbakhsh; Mahdieh Abbasalizad Farhangi; Koen Ponnet
Journal:  J Diabetes Metab Disord       Date:  2020-07-02

9.  Iran diabetes research roadmap (IDRR) study: a preliminary study on diabetes research in the world and Iran.

Authors:  Ensieh Nasli-Esfahani; Farshad Farzadfar; Marjan Kouhnavard; Robabeh Ghodssi-Ghassemabadi; Alireza Khajavi; Maryam Peimani; Rezvan Razmandeh; Mahboobeh Vala; Gita Shafiee; Camelia Rambod; Mahnaz Sanjari; Maryam Aalaa; Maryam Ghodsi; Farideh Razi; Fatemeh Bandarian; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2017-02-17

10.  Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016).

Authors:  Alireza Esteghamati; Bagher Larijani; Mohammad Haji Aghajani; Fatemeh Ghaemi; Jamshid Kermanchi; Ali Shahrami; Mohammad Saadat; Ensieh Nasli Esfahani; Morsaleh Ganji; Sina Noshad; Elias Khajeh; Alireza Ghajar; Behnam Heidari; Mohsen Afarideh; Jeffrey I Mechanick; Faramarz Ismail-Beigi
Journal:  Sci Rep       Date:  2017-10-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.